Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith M Kramer

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
JAMA|April 24, 2003
What clinicians should know about the QT intervalSana M Al-Khatib, Nancy M Allen LaPointe, Judith M Kramer, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 10, 2003
Knowledge deficits related to the QT interval could affect patient safetyNancy M Allen LaPointe, Sana M Al-Khatib, Judith M Kramer, et al.
Clinical Trials (London, England)|May 14, 2013
Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literatureDevon K Check, Kevin P Weinfurt, Carrie B Dombeck, et al.
Annals of Internal Medicine|May 21, 2003
Case reports of heart failure after therapy with a tumor necrosis factor antagonistHyon J Kwon, Timothy R Coté, Michael S Cuffe, et al.
Health Affairs (Project Hope)|March 9, 2006
Spending on postapproval drug safetyDavid B Ridley, Judith M Kramer, Hugh H Tilson, et al.
Medical Care|October 25, 2007
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databasesLesley H Curtis, Bradley G Hammill, Eric L Eisenstein, et al.
American Heart Journal|November 5, 2003
Evaluation of the dofetilide risk-management programNancy M Allen LaPointe, Anita Chen, Bradley Hammill, et al.
JAMA|May 3, 2012
Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010Robert M Califf, Deborah A Zarin, Judith M Kramer, et al.
American Heart Journal|June 17, 2004
Part II: Sealing holes in the safety netEric D Peterson, John W Hirshfeld, T Bruce Ferguson, et al.
The American Journal of Cardiology|May 26, 2009
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery diseaseNancy M Allen LaPointe, Yi Zhou, Judith A Stafford, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
JAMA|April 24, 2003
What clinicians should know about the QT intervalSana M Al-Khatib, Nancy M Allen LaPointe, Judith M Kramer, et al.
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|July 10, 2003
Knowledge deficits related to the QT interval could affect patient safetyNancy M Allen LaPointe, Sana M Al-Khatib, Judith M Kramer, et al.
Clinical Trials (London, England)|May 14, 2013
Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literatureDevon K Check, Kevin P Weinfurt, Carrie B Dombeck, et al.
Annals of Internal Medicine|May 21, 2003
Case reports of heart failure after therapy with a tumor necrosis factor antagonistHyon J Kwon, Timothy R Coté, Michael S Cuffe, et al.
Health Affairs (Project Hope)|March 9, 2006
Spending on postapproval drug safetyDavid B Ridley, Judith M Kramer, Hugh H Tilson, et al.
Medical Care|October 25, 2007
Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databasesLesley H Curtis, Bradley G Hammill, Eric L Eisenstein, et al.
American Heart Journal|November 5, 2003
Evaluation of the dofetilide risk-management programNancy M Allen LaPointe, Anita Chen, Bradley Hammill, et al.
JAMA|May 3, 2012
Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010Robert M Califf, Deborah A Zarin, Judith M Kramer, et al.
American Heart Journal|June 17, 2004
Part II: Sealing holes in the safety netEric D Peterson, John W Hirshfeld, T Bruce Ferguson, et al.
The American Journal of Cardiology|May 26, 2009
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery diseaseNancy M Allen LaPointe, Yi Zhou, Judith A Stafford, et al.
Pageof 5